The conference unfolded as a clear signal that cardiometabolic health has moved from a siloed clinical concern to a central business priority—and that employers, more than ever, are on the front lines of shaping outcomes.
The opening keynote from the Co-Founder of McKinsey’s Health Institute, Lars Hartenstein, PhD, set the tone with urgency and clarity: the conversation is no longer just about obesity, but about its broader role as a gateway to metabolic risk.
Employers heading into 2026 are facing a convergence of rising costs, expanding treatment options, and heightened employee expectations. The message is clear—understanding obesity as a chronic, multifactorial condition is foundational to any meaningful health strategy.
Following this, the first panel dove into the evolution of cardiometabolic interventions from lifestyle programs to pharmacotherapy, digital therapeutics, and device-based solutions. Technology emerged as both a catalyst and a challenge in the next session. Panelists explored how data, remote monitoring, and AI-enabled platforms are reshaping care delivery—but only when effectively integrated into clinical workflows. The future of cardiometabolic care isn’t just digital; it’s connected.
After the break, the conversation turned decisively practical. The panel on GLP-1 coverage brought one of the most pressing employer dilemmas into sharp focus: how to balance demand for highly effective—but expensive—therapies with sustainable benefits design.
“I thought the conference was a huge success. I appreciated the difference between presentations and panels. Overall, it provided a great, holistic view of a very complicated topic.”
- Gregg Nevola, Vice President and Head of Benefits for Northwell Health
At lunch, the topic turned toward foundations of health: food, sleep, movement, and recovery. While advanced therapies dominated earlier conversations, this session reminded attendees that sustainable cardiometabolic health is built on daily behaviors and these are not just individual responsibilities—they are influenced by workplace culture, benefits design, and environmental support.
That holistic perspective deepened in the afternoon sessions. The panel on breaking down silos challenged the traditional separation of heart disease, obesity, and diabetes, arguing for a unified approach to cardiometabolic care. Fragmentation, as several speakers noted, is no longer just inefficient—it’s ineffective.
The final session brought everything together with a focus on execution: building a cardiometabolic playbook requires more than awareness—it demands prioritization, sequencing, and accountability. Panelists emphasized starting with data: understanding population needs, identifying high-impact interventions, and scaling thoughtfully and with trusted partners.
Across every session, a few themes resonated consistently:
- Cardiometabolic health is now a strategic imperative for employers, not a peripheral concern.
- Innovation—whether in drugs, devices, or digital tools—must be matched with integration and oversight.
- The most effective strategies will be those that balance cutting-edge treatments with foundational health supports.
By the end of the day, one thing was clear: there is no single solution to cardiometabolic risk. But for employers willing to take a thoughtful, coordinated approach, there is a powerful opportunity to improve both health outcomes and organizational performance in the years ahead.
View the AGENDA to see all the above topics and speakers!
Resources from our Opening Keynote:
